Timothy Davis is an academic endocrinologist and general physician based at Fremantle Hospital. He is Principal Investigator of the Fremantle Diabetes Study, a community-based longitudinal observational study which has been running since 1993.

Dr Lisa Raven is an Endocrinologist at St Vincent’s Hospital Sydney, St Vincent’s Private Hospital and St Vincent’s Clinic. Lisa is undertaking her PhD at the University of New South Wales and the Garvan Institute of Medical Research, focusing on SGLT2 inhibition in heart transplant recipients. Lisa works closely with the Heart Failure and Heart Transplant Team at St Vincent’s Hospital Sydney and collaborates with the cardiologists on research focussing on SGLT2 inhibitors and GLP-1 receptor agonists. Lisa also works in the Diabetes Regional Education, Access and Management team, conducting diabetes case conferences in Rural and Regional New South Wales.

Professor Elif Ekinci is a clinician scientist, an academic endocrinologist who is working to translate research into improved outcomes for people with type 1 and type 2 diabetes. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans. She is the Weary Dunlop Medical Research Foundation Professorial Fellow in Metabolic Medicine and Dame Kate Campbell Fellow at The University of Melbourne, Department of Medicine, Austin Health. The Dame Kate Campbell Fellowship is given to researchers recognising incredible contributions to the University of Melbourne for outstanding research and wider involvement in our local community and across the globe. She has supervised 12 higher degrees to completion and is currently supervising 12 PhD students. She has over 200 peer reviewed publications in the leading diabetes, obesity and metabolism journals and has an H index of 40. She has attracted over $25 M in research funding and has received multiple awards for her work. She has had an accelerated career trajectory in the past five years, having had career disruptions to care for her three young children previously. She is also the Head of Diabetes at Austin Health, where she co-ordinates the clinical care of inpatients and outpatients with diabetes. She heads diabetes and obesity clinical trials at Austin Health at the Centre for Research and Education in Diabetes and Obesity. Prof Ekinci is the inaugural director of Australian Centre for Accelerating Diabetes Innovations (ACADI). In 2022, ACADI was established through MRFF funding from the Australian Government’s Targeted Translation Research Accelerator (TTRA) program, delivered by MTPConnect. ACADI has been awarded $10million from the Australian Government’s Medical Research Future Fund and received over $13million in cash and in- kind support from its partners. Led out of the University of Melbourne, ACADI will deliver novel interventions for timely diagnosis, prevention and treatment of diabetes and its complications with the access to clinical evaluation, leadership and networks, research commercialisation experience and workforce training. ACADI's design responds to key barriers slowing Australian development of innovations.

Jocelyn completed a PhD on ophthalmic complications of type 2 diabetes in 2021. She is a registered nurse, with a Master of Public Health. She worked on the landmark Fremantle Diabetes Study Phase II from 2013 until she joined Lions Outback Vision in 2022. She is working towards improving health outcomes for those living in remote WA, who are often disadvantaged. She is particularly interested in diabetic retinopathy screening.